Neurologic Disorders Resource Center
Click on the subcategory below to find drug monographs for that particular area.
Cinnamon: A Future Treatment for MS?
Looking for a Job?
New Data on Qudexy XR
People with Dementia Often Not Screened
Parkinson's Meds May Spur Compulsive Behaviors
No Link Between Vaccines, Multiple Sclerosis
Can Cocoa Improve Memory Loss?
Herpes Simplex Virus and Alzheimer's Disease
Clinical Charts
Make prescribing decisions with our comparative charts and treatment algorithms.
Patient Information Fact Sheets
Download or print easy-to-read disease leaflets for your patients.
Industry Supported Education
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
News
Overactive Bladder Drug May be Beneficial in MS
Researchers from the University of Buffalo have found a way to improve remyelination for myelin-based diseases like multiple sclerosis (MS).
FDA to Review Investigational Parkinson's Disease Drug Xadago
The FDA has accepted for filing the New Drug Application (NDA) for Xadago (safinamide; Newron and Zambon) as add-on therapy in both early and mid-to-late stage Parkinson's disease (PD) patients who are inadequately managed on their current treatment.
How Prevalent is Antipsychotic Prescribing in Seniors with Dementia?
An analysis by the United States Government Accountability Office (GAO) has found that about 1/3 of older adults with dementia who resided >100 days in a nursing home in 2012 were prescribed an antipsychotic.
Cannabis Linked to Increased Stroke Risk
Temporal relationship between cannabis exposure, index event exhibited in 81 percent of cases
FEATURES
Is Roseroot a Reliable Alternative for Nervous System Ailments?
The perennial plant has been used to treat depression, muscle weakness and muscle fatigue.
Treating Traumatic Brain Injury in Young Athletes
Accurate identification, assessment and evaluation of concussions will enable clinicians to determine when it is safe for young athletes to return to competition.
Drug Therapies for Restless Legs Syndrome
Willis-Ekbom disease, otherwise known as restless legs syndrome, is a neurologic disorder that affects up to 10% of Americans. Individuals with RLS develop irresistible urges to move their legs accompanied by unusual or unpleasant sensations in the legs.
Featured courses from mycme
Comprehensive Review of Electrodiagnostic Medicine and Neuromuscular Disorders
Led by Program Directors Anthony A. Amato, MD, and William S. David, MD, PhD, authoritative ...
UCLA Review of Clinical Neurology
Led by Course Chair Alon Avidan, MD, MPH, the authoritative faculty of The UCLA Review ...
Musculoskeletal, Neurologic, Psych/Behavioral Science
This module reviews all topics on the NCCPA examination blueprint relating to the Musculoskeletal, Neurologic, ...
MPR Articles
- Recall of Two IV Antibiotics Announced
- Five Things ID Experts Want You to Know Before You Prescribe an Antibiotic
- What's Changed in Immunization Recommendations From CDC Advisory Committee
- IUD Approval Gives Women New Long-Acting Birth Control Option
- Vitamin D: Greater Risk Factor for Diabetes Than Weight?
- Number of Docs, Retail Clinics Affect Antibiotic Prescribing Rate
- More Evidence Points to the Power of Nuts in Reducing CVD Mortality
- Overactive Bladder Drug May be Beneficial in MS
- FDA to Review Investigational Parkinson's Disease Drug Xadago
- How Prevalent is Antipsychotic Prescribing in Seniors with Dementia?